 random prospect studi topic antimicrobi agent skin graft thermal injuri consecut patient earli tangenti excis thermal injuri use topic antimicrobi agent silver nitrat Ag gm/liter bacitracin units/lit NB effect ringer lactat RL prevent autogen skin-graft loss due infect graft loss percent patient percent due skin-graft loss minor problem patient percent total bodi surfac area tbsa burn Ag NB RL use antimicrobi Ag NB graft loss RL percent tbsa burn group larg burn percent high incid percent graft loss percent regardless treatment infect area graft loss antibiotic-resist organ yeast percent ringer lactat group entir neomycin bacitracin group graft infect resist organ yeast silver nitrat group studi topic antimicrobi agent infection-rel skin-graft loss patient medium-s percent tbsa burn neomycin bacitracin rapid emerg drug-resist organ silver nitrat